Afya Ltd Newsroom

BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsNov 14 10:31 ET

Morgan Stanley Maintains Afya Ltd(AFYA.US) With Hold Rating, Raises Target Price to $19

Moomoo NewsNov 14 07:34 ET

BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsNov 14 05:34 ET

BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating, Announces Target Price $25

Moomoo NewsOct 30 07:37 ET

Morgan Stanley Maintains Afya Ltd(AFYA.US) With Hold Rating, Maintains Target Price $18

Moomoo NewsOct 30 06:35 ET

BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating

Moomoo NewsOct 18 09:31 ET

Afya Initiated at Neutral by UBS

Dow JonesAug 30 09:33 ET

Afya Price Target Announced at $19.50/Share by UBS

Dow JonesAug 30 09:33 ET

Afya Analyst Ratings

BenzingaAug 30 09:24 ET

BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsAug 15 09:31 ET

Morgan Stanley Maintains Afya Ltd(AFYA.US) With Hold Rating, Cuts Target Price to $18

Moomoo NewsAug 15 06:31 ET

BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating, Raises Target Price to $25

Moomoo NewsAug 15 05:33 ET

Afya Analyst Ratings

BenzingaJun 21 06:28 ET

Morgan Stanley Downgrades Afya to Equal-Weight, Raises Price Target to $23

BenzingaJan 22 05:50 ET

Afya Analyst Ratings

BenzingaJan 22 05:48 ET

Afya Analyst Ratings

BenzingaNov 27, 2023 06:04 ET

Morgan Stanley Upgrades Afya to Overweight, Raises Price Target to $20.5

BenzingaOct 13, 2023 05:50 ET

Afya Analyst Ratings

BenzingaOct 13, 2023 05:49 ET

Credit Suisse Adjusts Afya's Price Target to $18 From $19, Keeps Outperform Rating

MT NewswiresNov 22, 2022 10:01 ET

Afya Analyst Ratings

Benzinga Analyst RatingsNov 22, 2022 08:38 ET